Citius Pharmaceuticals, Inc. Public Float
Citius Pharmaceuticals, Inc. (CTXR) had Public Float of $11.39 million as of 2025-03-31, per its 10-K/A filed 2026-01-28.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-01-28
- 2025-03-31: Entity Public Float $11.39M.
- 2024-03-28: Entity Public Float $131.67T.
- 2023-03-31: Entity Public Float $156.90M.
- 2022-03-31: Entity Public Float $240.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-03-31 | $11.39M 10-K/A · filed 2026-01-28 |
| 2024-03-28 | $131.67T 10-K/A · filed 2025-01-27 |
| 2023-03-31 | $156.90M 10-K · filed 2023-12-29 |
| 2022-03-31 | $240.00M 10-K · filed 2022-12-22 |
| 2021-03-31 | $218.00M 10-K · filed 2021-12-15 |
| 2020-03-31 | $15.50M 10-K · filed 2020-12-16 |
| 2019-03-29 | $9.00M 10-K · filed 2019-12-16 |
| 2018-03-31 | $19.70M 10-K · filed 2018-12-11 |
| 2017-03-31 | $14.44M 10-K · filed 2017-12-13 |
| 2016-03-31 | $14.81M 10-K · filed 2016-12-23 |
| 2015-03-31 | $6.64M 10-K · filed 2015-12-14 |
| 2014-03-31 | $0.00 10-KT · filed 2014-12-29 |
| 2013-03-31 | $0.00 10-K · filed 2014-02-06 |
| 2012-03-31 | $0.00 10-K · filed 2013-01-15 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-26 |
| 2011-03-31 | $0.00 10-K · filed 2012-01-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |